Komori
Seihyo (2872) · FactInterim R&D expenses increased

R&D activity expenses

First written in FY2018-Q3. 6 of 29 entries say "Advanced", first in FY2019. Latest entry: FY2027-H1.

29entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q3 – FY2019-Q3OtherFY2025-Q1 – FY2027-H12018: 320182019: 420192020: 420202021: 420212022: 420222023: 420232024: 420242025: 120252026: 12026
Same theme, other companies
Decline in R&D spendingA theme 50 companies write about · 46 as a headwind · 4 as a tailwind

42 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Interim R&D expenses increasedAnnual report

    「Research and development expenditure during the interim accounting period was ¥9,355 thousand.」

    Research and development expenditure for the interim accounting period was disclosed as ¥9,355 thousand.
  2. FY2026-H1Updated interim research and development expensesAnnual report

    「The amount of research and development activity for the interim accounting period was ¥6.415 million.」

    R&D expenditure for the interim accounting period was disclosed as ¥6.415 million, down from ¥8.219 million in the same period of the previous year.
  3. FY2025-H1Updated interim research and development expensesAnnual report

    「The amount of research and development activity for the interim accounting period was ¥8.219 million.」

    R&D expenditure for the interim accounting period was disclosed as ¥8.219 million.
  4. FY2025-Q1Update to first-quarter R&D expensesAnnual report

    「The amount of research and development activity for the cumulative first quarter period was ¥3.799 million.」

    R&D expenditure for the cumulative first quarter period was disclosed as ¥3.799 million.
  5. FY2024AdvancedAnnual report

    「During the fiscal year, we launched 15 new products. Going forward, the Product Development Committee, led by the Product Development Office, will continue developing safe, reliable and delicious products from the customer’s perspective and working to create attractive “high-value-added products.”」

    As a result of its R&D activities, the company launched 15 new products and continues developing high-value-added products centered on the Product Development Office and Product Development Committee.
  6. FY2024-Q3Cumulative R&D expenditure decreased year on yearAnnual report

    「The amount of research and development activity for the cumulative third quarter period was ¥10.382 million.」

    R&D expenditure for the cumulative third quarter period was ¥10.382 million, down from ¥11.863 million in the same period of the previous year. The company stated that there had been no material change in the status of its R&D activities.
  7. FY2024-Q2Updated cumulative R&D expensesAnnual report

    「The amount of research and development activity for the cumulative second quarter period was ¥7.452 million.」

    R&D expenditure for the cumulative second quarter period was disclosed as ¥7.452 million. The company stated that there had been no material change in the status of its R&D activities.
  8. FY2024-Q1Update to first-quarter R&D expensesAnnual report

    「The amount of research and development activity for the cumulative first quarter period was ¥3.530 million.」

    R&D expenditure for the cumulative first quarter period was disclosed as ¥3.530 million, a decrease from ¥4.077 million in the same period of the previous year.
  9. FY2023AdvancedAnnual report

    「During the fiscal year, we launched 8 new products and renovated 7 existing products.」

    As a result of its R&D activities, the company launched 8 new products and renovated 7 existing products.
  10. FY2023-Q3Updated cumulative R&D expensesAnnual report

    「The amount of research and development activity for the cumulative third quarter period was ¥11.863 million.」

    R&D expenditure for the cumulative third quarter period was disclosed as ¥11.863 million. The company stated that there had been no material change in the status of its R&D activities.
  11. FY2023-Q2Updated cumulative R&D expensesAnnual report

    「The amount of research and development activity for the cumulative second quarter period was ¥8.131 million.」

    R&D expenditure for the cumulative second quarter period was disclosed as ¥8.131 million.
  12. FY2023-Q1Update to first-quarter R&D expensesAnnual report

    「The amount of research and development activity for the cumulative first quarter period was ¥4.077 million.」

    R&D expenditure for the cumulative first quarter period was disclosed as ¥4.077 million.
  13. FY2022AdvancedAnnual report

    「During the fiscal year, we launched 15 new products and renovated 1 existing product. Going forward, the Product Development Committee, centered on the Product Development Office, will continue developing safe, reliable and delicious products from the customer's perspective and work to create attractive, high-value-added products.」

    Centered on the Product Development Office and Product Development Committee, the company launched 15 new products and renovated 1 existing product.
  14. FY2022-Q3Updated cumulative R&D expensesAnnual report

    「The amount of research and development activity for the cumulative third quarter period was ¥9.107 million.」

    R&D expenditure for the cumulative third quarter period was disclosed as ¥9.107 million.
  15. FY2022-Q2Updated cumulative R&D expensesAnnual report

    「The amount of research and development activity for the cumulative second quarter period was ¥5.726 million.」

    R&D expenditure for the cumulative second quarter period was disclosed as ¥5.726 million.
  16. FY2022-Q1Update to first-quarter R&D expensesAnnual report

    「The amount of research and development activity for the cumulative first quarter period was ¥3.012 million.」

    R&D expenditure for the cumulative first quarter period was disclosed as ¥3.012 million.
  17. FY2021AdvancedAnnual report

    「During the fiscal year, we launched 19 new products and renovated 1 existing product.」

    As a result of its R&D activities, the company launched 19 new products and renovated 1 existing product.
  18. FY2021-Q3Updated cumulative R&D expensesAnnual report

    「The amount of research and development activity for the cumulative third quarter period was ¥9.947 million.」

    R&D expenditure for the cumulative third quarter period was disclosed as ¥9.947 million. The company stated that there had been no material change in the status of its R&D activities.
  19. FY2021-Q2Updated cumulative R&D expensesAnnual report

    「The amount of research and development activity for the cumulative second quarter period was ¥6.350 million.」

    R&D expenditure for the cumulative second quarter period was disclosed as ¥6.350 million. The company stated that there had been no material change in the status of its R&D activities.
  20. FY2021-Q1Updated quarterly research and development expensesAnnual report

    「The amount of research and development activity for the cumulative first quarter period was ¥2.884 million.」

    R&D expenditure for the cumulative first quarter period was disclosed as ¥2.884 million, compared with ¥2.644 million in the same period of the previous year.
  21. FY2020AdvancedAnnual report

    「During the fiscal year, we launched 13 new products and renovated 5 existing products.」

    As a result of its R&D activities, the company launched 13 new products and renovated 5 existing products.
  22. FY2020-Q3Updated cumulative R&D expensesAnnual report

    「The amount of research and development activity for the cumulative third quarter period was ¥8.060 million.」

    R&D expenditure for the cumulative third quarter period was disclosed as ¥8.060 million. The company stated that there had been no material change in the status of its R&D activities.
  23. FY2020-Q2Updated quarterly research and development expensesAnnual report

    「The amount of research and development activity for the cumulative second quarter period was ¥5.462 million.」

    R&D expenditure for the cumulative second quarter period was disclosed as ¥5.462 million. The company stated that there had been no material change in the status of its R&D activities.
  24. FY2020-Q1Updated quarterly research and development expensesAnnual report

    「The amount of research and development activity for the cumulative first quarter period was ¥2.644 million.」

    R&D expenditure for the cumulative first quarter period was disclosed as ¥2.644 million. The company also stated that there had been no material change in the status of its R&D activities.
  25. FY2019AdvancedAnnual report

    「During the fiscal year, we launched 15 new products and 1 renovated existing product. Going forward, the Product Development Committee, centered on the Product Development Office, will continue developing safe, reliable and delicious products from the customer's perspective and work to create attractive, high-value-added products.」

    As part of its R&D activities, the company launched 15 new products and renovated 1 existing product, and continues to develop high-value-added products.
  26. FY2019-Q3Updated quarterly research and development expensesAnnual report

    「The amount of research and development activity for the cumulative third quarter period was ¥6.902 million.」

    R&D expenditure for the cumulative third quarter period was disclosed as ¥6.902 million.
  27. FY2019-Q2Updated quarterly research and development expensesAnnual report

    「The amount of research and development activity for the cumulative second quarter period was ¥4.554 million.」

    R&D expenditure for the cumulative second quarter period was disclosed as ¥4.554 million.
  28. FY2019-Q1Updated quarterly research and development expensesAnnual report

    「The amount of research and development activity for the cumulative first quarter period was ¥2.073 million.」

    R&D expenditure for the cumulative first quarter period was disclosed as ¥2.073 million.
  29. FY2018-Q3First statedAnnual report

    「The amount of research and development activity for the cumulative third quarter period was ¥4.705 million.」

    R&D expenditure for the cumulative third quarter period was disclosed as ¥4.705 million.
Moved together

"Development of High-Value-Added Products" moved the same way as this thread, in the same document, in 6 of its 29 moves.

664444★123456
  1. ★This thread
  2. 1Development of High-Value-Added Products6×
  3. 2Streamlining Ice Cream Production6×
  4. 3Sales of Own, OEM and Private-Brand Products4×
  5. 4Operating Profit, Ordinary Profit and Quarterly Net Profit Turn Profitable4×
  6. 5Strengthening Sales and Price Revisions for Own Products4×
  7. 6Increase in Net Assets and Retained Earnings4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Seihyo yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
R&D activity expenses | SEIHYO CO.,LTD. (2872) | Komori